KPF
TECX

K2 Principal Fund’s Tectonic Therapeutic TECX Stock Holding History

K2 Principal Fund’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-228,201
Closed -$1.76M – 328
2022
Q3 		$1.76M Buy
228,201
+135,270
+146% +$1.5M 0.2% 103
2022
Q2 		$1.03M Buy
+92,931
New +$1.1M 0.11% 155

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

K2 Principal Fund's TECX Position: Q4 2022 in Review

K2 Principal Fund sold out of Tectonic Therapeutic (TECX) in Q4 2022, closing a stake of 228,201 shares — an estimated $1.76M sold.

K2 Principal Fund first reported a position in TECX in Q2 2022 and held it in 2 quarters. The position peaked at $1.76M in Q3 2022. 45 funds tracked by Wall St. Rank hold TECX as of Q4 2022.

  • K2 Principal Fund reported no remaining Tectonic Therapeutic position as of Q4 2022 after selling out during the quarter.
  • K2 Principal Fund sold 228,201 Tectonic Therapeutic shares in Q4 2022, an estimated $1.76M.
  • K2 Principal Fund first reported a position in Tectonic Therapeutic in Q2 2022 and held it in 2 quarters.
  • K2 Principal Fund's Tectonic Therapeutic position peaked at $1.76M in Q3 2022.
  • 45 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2022.

Based on K2 Principal Fund's 13F filing for Q4 2022, filed 10 Feb 2023.